Skip to main content

Motorola Launches First Bioarray; More Set to Follow Through January

NEW YORK, Aug. 15 – Motorola Life Sciences introduced its high-density human genome bioarray on Wednesday as part of its CodeLink bioarray systems launch.

The introduction, made at the Drug Discovery Technology 2001 conference in Boston, launches Motorola’s Uniset Human I bioarray, which the company said includes approximately 9,200 unique oligonucleotides representing human EST clusters. 

The bioarray content comes from sequences in the public UniGene database that was compared and confirmed against Incyte’s LifeSeq database, Scott Magnuson, Motorola Life Sciences’ head of genomics and bioinformatics, told GenomeWeb .

The launch marks the first in a series of bioarrays that Motorola has scheduled to unveil over the next five months, according to Mike James, vice president of commercial operations at Motorola Life Sciences. 

These products include a 10K rat genome bioarray, which is slated to appear in September; a Uniset II human array that features additional UniGene data plus data from Incyte, scheduled to be introduced around the end of the year; and an array designed to measure SNPs within the P450 gene family, which will launch at year’s end.

All of the bioarrays are designed around Motorola’s new CodeLink software and database platform. 

The Uniset Human I bioarray is targeted at researchers already using pre-fabricated arrays in addition to researchers who self-spot, said Bill Coty, Motorola Life Sciences’ director of product development.  

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.